The CARDIOLIPID Plan: A Cardiovascular Risk-centred Implementation Framework for the Diagnosis and Management of Dyslipidaemia: Experts’ Proposal
European Cardiology Review · 09.07.2026
DOI: 10.15420/ecr.2026.08 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Cardiology Review, online erschienen am 09.07.2026. Verfasst von Stanisław Surma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia Katowice, Poland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Dyslipidaemia remains a major contributor to cardiovascular morbidity and mortality, despite the availability of effective lipid-lowering therapies and well-established European Society of Cardiology/European Atherosclerosis Society guidelines. In clinical practice, the implementation of these recommendations is often suboptimal, with persistent therapeutic inertia and fragmented decision-making processes. The CARDIOLIPID Plan is a proposed cardiovascular risk-centred implementation framework designed to support the practical application of guideline-based care. The model integrates two key components of clinical decision-making: comprehensive cardiovascular risk assessment (CARDIO) and personalised lipid-lowering intervention (LIPID), structured into a sequential and clinically applicable pathway. While the individual elements of the CARDIOLIPID Plan are derived from current evidence and guideline recommendations, their organisation within this framework reflects an interpretation by experts aimed at improving clarity, usability and clinical implementation. The model emphasises early and appropriate treatment intensification, reduction of therapeutic inertia and a holistic, patient-centred approach to cardiovascular risk management. The CARDIOLIPID Plan may serve as a practical tool to enhance the translation of evidence into clinical practice. However, as a conceptual and implementation-oriented framework, it requires validation in real-world settings to assess its impact on treatment outcomes and cardiovascular risk reduction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia Katowice, Poland.
- Department of Internal Diseases and Cardiac Rehabilitation, Medical University of Lodz Lodz, Poland.
- University Hospital Erlangen, Friedrich Alexander University Erlangen-Nuremberg Germany.
- Hypertension and Cardiovascular Risk Research Center, Medical and Surgical Sciences Department, Alma Mater Studiorum - University of Bologna Bologna, Italy.
- University of Milano-Bicocca Milan, Italy.
- Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital Liverpool, UK.
ORCID-Profile: Stanisław Surma, Marcin Barylski, Roland E Schmieder, Claudio Borghi, Giuseppe Mancia, Gregory Yh Lip, Krzysztof J Filipiak
Zitieren
APA
Surma, S., Barylski, M., Schmieder, R. E., Borghi, C., Mancia, G., Lip, G. Y., & Filipiak, K. J. (2026). The CARDIOLIPID Plan: A Cardiovascular Risk-centred Implementation Framework for the Diagnosis and Management of Dyslipidaemia: Experts’ Proposal. European Cardiology Review. https://doi.org/10.15420/ecr.2026.08
Vancouver
Surma S, Barylski M, Schmieder RE, Borghi C, Mancia G, Lip GY, et al. The CARDIOLIPID Plan: A Cardiovascular Risk-centred Implementation Framework for the Diagnosis and Management of Dyslipidaemia: Experts’ Proposal. European Cardiology Review. 2026. doi:10.15420/ecr.2026.08
BibTeX
@article{Surma2026,
author = {Surma, Stanisław and Barylski, Marcin and Schmieder, Roland E and Borghi, Claudio and Mancia, Giuseppe and Lip, Gregory Yh and Filipiak, Krzysztof J},
title = {The CARDIOLIPID Plan: A Cardiovascular Risk-centred Implementation Framework for the Diagnosis and Management of Dyslipidaemia: Experts’ Proposal},
journal = {European Cardiology Review},
year = {2026},
doi = {10.15420/ecr.2026.08}
}
EUVIMED